SOLV Stock: Solventum Corporation Stock Price, Analysis & Insights
Get live solv stock price $83.38, comprehensive Solventum Corporation stock analysis, charts, news, and expert forecast. Real-time solv stock data and investment insights.
Loading chart...
Company Overview
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.
Company Information
- CEO
- Bryan C. Hanson
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Employees
- 22000
Contact Information
- Website
- https://www.solventum.com
- Address
- 3M Center
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 9.6)
✓ Lower volatility stock (Beta: 0.61) may provide portfolio stability
Business Model & Strategy
Solventum Corporation operates in the Medical - Care Facilities industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Bryan C. Hanson, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Care Facilities model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Solventum Corporation competes in the Medical - Care Facilities within the broader Healthcare. With 14.5 billion in market capitalization, the company is positioned as a established player in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the New York Stock Exchange, Solventum Corporation provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Solventum Corporation should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Solventum Corporation shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Solventum Corporation
- ⚠Investors should consider how Solventum Corporation fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
14.46B
P/E Ratio
9.57
Beta
0.61
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 14.46B market capitalization
- Trading Volume: 756.12K shares traded today
- Price Range: 52-week range of $60.70 - $85.92
- Exchange: Listed on New York Stock Exchange
Financial Metrics
Market Analysis for Solventum Corporation
Solventum Corporation (SOLV) operates in the Medical - Care Facilities industry within the Healthcare sector. With a current market capitalization of 14.46B, the company represents a significant player in its market. The stock is currently trading at $83.38 with a positivedaily change of 0.58%.
The company's 22000 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 9.57, beta of 0.61, and 52-week price range from $60.70 to $85.92when evaluating investment opportunities.
Why Invest in Solventum Corporation?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange)
- • Experienced leadership under Bryan C. Hanson
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.